Cannabis Oil

FDA warns Curaleaf about inflated claims in CBD product marketing



A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is …

Related Articles

Check Also

Close
Back to top button
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker